🇺🇸 FDA
Patent

US 8389495

Olioodeoxynucleotide and its use to induce an immune response

granted A61KA61K2039/55561A61K31/7088

Quick answer

US patent 8389495 (Olioodeoxynucleotide and its use to induce an immune response) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Feb 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as Represented by the Secretary of the Department of Health and Human Services
Grant date
Tue Mar 05 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
23
CPC classes
A61K, A61K2039/55561, A61K31/7088, A61K38/00, A61K39/008